https://eastwestbiobrief.com/2026-11-06daily1.0 https://eastwestbiobrief.com/benchmark/2026-11-06quarterly0.9 https://eastwestbiobrief.com/benchmark.json2026-11-06quarterly0.85 https://eastwestbiobrief.com/medtech-benchmark/2026-11-06quarterly0.9 https://eastwestbiobrief.com/medtech-benchmark.json2026-11-06quarterly0.85 https://eastwestbiobrief.com/episodes/2026-11-06-daily-bayer-sunharbo-qyuns-hinova-innocare/2026-11-06monthly0.8 https://eastwestbiobrief.com/episodes/2026-11-05-daily-hemay-postponed-sino-biopharm-boehringer-nxera/2026-11-05monthly0.8 https://eastwestbiobrief.com/episodes/2026-11-04-daily-china-ipo-pause-atom-gout-hemay-nanochap/2026-11-04monthly0.8 https://eastwestbiobrief.com/episodes/2026-11-03-daily-fresenius-wuxi-biosimilars-uniqure-huntingtons-vaxcell/2026-11-03monthly0.8 https://eastwestbiobrief.com/episodes/2026-11-02-daily-akeso-ivonescimab-ai-drug-design-daewoong-licence/2026-11-02monthly0.8 https://eastwestbiobrief.com/episodes/2026-10-31-pilot-asia-biotech-decoded-for-investors/2026-10-31monthly0.8